|
No images? Click here 
Dear dupa, Biopharma is heading into a pivotal 2026, and we need your perspective on where things are actually heading. Endpoints is fielding the next Biopharma Sentiment Index (BPSI) — a concise, three-minute survey. It distills thousands of viewpoints from executives, investors, scientists and policy leaders into an easy-to-read quarterly benchmark. The BPSI is one of the clearest snapshots we have of how people inside biopharma see the year ahead. Responses are confidential. More than 1,400 people took part last quarter. We need your participation to keep this benchmark representative and effective for the biopharma community. Your answers will help shape the industry’s thinking as people plan for the year ahead. Participants will be the first to receive a complimentary copy of the report. Thanks for weighing in, Tom Randall 
2029 Becker Drive; Lawrence, Kansas 66047 Privacy and deletion: help@endpointsnews.com    Worldwide made. Thanks for reading. |
